company

FIRBENT TERAPI AS

4019 STAVANGER

Return on Equity
−400 %
Current Ratio
0,77
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue609 000
Net Income104 000
Total Assets291 000
Total Equity−26 000
Income (NOK)2022
Revenue609 000
Expenditure529 000
Operating Profit81 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax81 000
Tax−23 000
Net Income104 000
Balance (NOK)2022
Total Fixed Assets46 000
Total Current Assets244 000
Total Assets291 000
Total Retained Equity−83 000
Total Equity−26 000
Total Long-Term Debt0
Total Current Debt317 000
Total Equity and Debt291 000
Cash flow (NOK)2022
Sales Income404 000
Other Income205 000
Revenue609 000
Cost of Goods Sold47 000
Salary Costs131 000
Depreciation0
Impairment10 000
Expenditure529 000
Operating Profit81 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income104 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets23 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures23 000
Total Tangible Assets23 000
Total Fiancial Fixed Assets0
Total Fixed Assets46 000
Stock0
Total Investments0
Cash, Bank209 000
Total Current Assets244 000
Total Assets291 000
Total Equity−26 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors59 000
Unpaid Taxes11 000
Dividends0
Other Current Debt247 000
Total Current Debt317 000
Total Equity and Debt291 000
Financial indicators2022
Return on Equity−400 %
Debt-to-Equity Ratio−0
Operating Profit Margin13,3 %
Current Ratio0,77
Quick Ratio0,77
Equity Ratio−0,09
Gross Profit Margin92,28 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English